Why choose UCLA Health for prostate cancer care?
The UCLA Health Prostate Cancer Program is part of the Institute of Urologic Oncology at the Jonsson Comprehensive Cancer Center (JCCC). The JCCC has an international reputation for providing the best in experimental and traditional cancer treatments.
Our prostate cancer specialists provide:
Comprehensive, compassionate care: The Prostate Cancer Program at UCLA Health offers the latest treatments with personalized, empathetic care.
Expertise in high-risk patients: While our physicians treat all stages of prostate cancer, we frequently treat patients with complex cases, referred here by other hospitals.
Access to innovative research: Our scientists have been making groundbreaking discoveries for decades. We offer our patients the opportunity to join our pioneering clinical trials.
Superior care, close to home: UCLA Health offers prostate cancer services in many community cancer clinics across the greater Los Angeles region. This means you can receive high-quality care that’s convenient for you and close to home.
From diagnosis to rehabilitation, we offer comprehensive prostate cancer services, including:
Early detection and diagnosis
At UCLA Health, we use state-of-the-art technology to detect cancer in its early stages, when it’s most treatable. If we find prostate cancer, you may need additional testing, such as:
Prostate-specific antigen (PSA) test: A blood test that checks for elevated levels of a protein made by the prostate called prostate-specific antigen (PSA). This protein is a biomarker for prostate cancer. Biomarkers are subtle changes in genes or proteins that might be a sign of cancer.
4Kscore® and PHI test: Blood tests that evaluate PSA levels to deliver a precise diagnosis and help doctors plan treatment.
PCA3 and MDx Select: Urinary lab tests that check for biomarkers in at-risk men.
Digital rectal exam: An internal prostate examination. During a rectal exam, your doctor places a gloved finger in your rectum to feel for lumps on your prostate.
Prostate-specific membrane antigen (PSMA) PET scan: An advanced scanning technology that can locate prostate tumors with unprecedented precision.
Prostate biopsy: A procedure used to extract a tissue sample from your prostate. During the biopsy, the surgeon will guide the device through the rectal wall and the prostate with ultrasound or MRI imaging.
Our Genitourinary Cancer Genetic Risk Assessment Program evaluates the potential genetic factors that can increase a man’s risk for prostate cancer. Knowing about a specific genetic risk can help doctors more precisely tailor a treatment plan that is optimal for you. Learn more about the cancer genetics program at UCLA Health.
After prostate surgery, some men experience problems maintaining erections or controlling urine. We offer the following services to help men take back control:
Pelvic floor rehabilitation: Physical therapy for urinary incontinence caused by prostate cancer surgery or radiation.
Post-prostatectomy rehabilitation: Treatments for erectile dysfunction caused by prostate cancer surgery or radiation.
Prostate cancers we treat
We successfully treat a wide range of prostate cancers, including:
Adenocarcinoma: The most common form of prostate cancer. Adenocarcinoma starts in the gland cells of the prostate.
Neuroendocrine tumors (or carcinoids): Tumors that originate in the endocrine system.
Sarcoma of the prostate: A rare form of prostate cancer that forms in the prostate’s smooth muscle cells. The tumor can spread to the bladder and rectum.
Small cell carcinoma: An aggressive type of hormone-based prostate cancer that is often found in late stages.
Treatments we offer
UCLA Health has many options for treating prostate cancer, including:
Active surveillance: A delayed treatment approach that is appropriate for men who have low-risk and slow-growing cancer. Active surveillance includes regular testing and imaging.
Hormone therapy: Medications used to decrease testosterone levels in the body. Prostate cancer feeds off testosterone, so lowering the amount of this hormone can help slow cancer growth.
Chemotherapy: Powerful drugs given intravenously or in pill form to damage and kill cancer cells.
Provenge®: An FDA-approved cancer vaccine and immunotherapy drug that uses a modified form of a patient’s immune cells to recognize and destroy prostate cancer cells.
High-intensity focused ultrasound (HIFU): A procedure that delivers focused sound waves to kill cancer cells on a targeted spot of prostate tissue.
When given in high doses, radiation can damage or kill cancer cells. At UCLA Health, we offer:
Brachytherapy: A procedure that uses radioactive pellets to deliver targeted radiation. The pellets are inserted into the prostate and remain in place for months. Brachytherapy spares healthy tissue by focusing its steady, high-dose radiation more precisely.
External beam radiation therapy: A localized form of high-dose radiotherapy that spares healthy tissues that surround a tumor.
Stereotactic body radiotherapy: A focused radiation treatment delivered over five sessions that uses 3D imaging to target tumors.
Surgery can help cure early stage prostate cancer that has not spread to surrounding organs. Procedures include:
Radical prostatectomy: The surgical removal of the entire prostate. Surgeons at UCLA Health typically perform this procedure using a minimally invasive, robotic-assisted approach. This type of surgery enables surgeons to preserve sexual function and urinary control.
Lymph node dissection: Removal of the lymph nodes near the prostate. We may use this for men with advanced or recurrent prostate cancer.
Our expert team
UCLA Health is home to some of the top prostate cancer specialists in the country. They use the most advanced technologies available and innovative research to diagnose and treat prostate cancer.
Call 310-794-7700 to request an appointment with a prostate cancer specialist at UCLA Health.